198 related articles for article (PubMed ID: 25931375)
1. Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation.
Liu J; Wang J; Fan L; Chen X; Hu D; Deng X; Poon HF; Wang H; Liu X; Tan WS
World J Microbiol Biotechnol; 2015 Jul; 31(7):1147-56. PubMed ID: 25931375
[TBL] [Abstract][Full Text] [Related]
2. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
3. Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile.
Lee JH; Jeong YR; Kim YG; Lee GM
Biotechnol Bioeng; 2017 Aug; 114(8):1721-1732. PubMed ID: 28266015
[TBL] [Abstract][Full Text] [Related]
4. Effect of Bcl-xL overexpression on sialylation of Fc-fusion protein in recombinant Chinese hamster ovary cell cultures.
Lee JH; Kim YG; Lee GM
Biotechnol Prog; 2015; 31(4):1133-6. PubMed ID: 26018766
[TBL] [Abstract][Full Text] [Related]
5. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the impact of suramin additive on CHO cells producing Fc-fusion protein.
Lim JH; Cha HM; Han HJ; Kim DI
Biotechnol Lett; 2019 Nov; 41(11):1255-1263. PubMed ID: 31541331
[TBL] [Abstract][Full Text] [Related]
7. Insights into the loss of protein sialylation in an fc-fusion protein-producing CHO cell bioprocess.
Chen X; Liu X; Xiao Z; Liu J; Zhao L; Tan WS; Fan L
Appl Microbiol Biotechnol; 2019 Jun; 103(12):4753-4765. PubMed ID: 31049620
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
Baker KN; Rendall MH; Hills AE; Hoare M; Freedman RB; James DC
Biotechnol Bioeng; 2001 May; 73(3):188-202. PubMed ID: 11257601
[TBL] [Abstract][Full Text] [Related]
9. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap.
Clark KJ; Griffiths J; Bailey KM; Harcum SW
Biotechnol Bioeng; 2005 Jun; 90(5):568-77. PubMed ID: 15818560
[TBL] [Abstract][Full Text] [Related]
10. Monitoring sialylation levels of Fc-fusion protein using size-exclusion chromatography as a process analytical technology tool.
Liu J; Chen X; Fan L; Deng X; Fai Poon H; Tan WS; Liu X
Biotechnol Lett; 2015 Jul; 37(7):1371-7. PubMed ID: 25782436
[TBL] [Abstract][Full Text] [Related]
11. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
Gramer MJ; Eckblad JJ; Donahue R; Brown J; Shultz C; Vickerman K; Priem P; van den Bremer ET; Gerritsen J; van Berkel PH
Biotechnol Bioeng; 2011 Jul; 108(7):1591-602. PubMed ID: 21328321
[TBL] [Abstract][Full Text] [Related]
12. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
Naso MF; Tam SH; Scallon BJ; Raju TS
MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
[TBL] [Abstract][Full Text] [Related]
13. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
14. Sialylation enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary cells by dexamethasone.
Jing Y; Qian Y; Li ZJ
Biotechnol Bioeng; 2010 Oct; 107(3):488-96. PubMed ID: 20521303
[TBL] [Abstract][Full Text] [Related]
15. Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics.
Saldova R; Kilcoyne M; Stöckmann H; Millán Martín S; Lewis AM; Tuite CM; Gerlach JQ; Le Berre M; Borys MC; Li ZJ; Abu-Absi NR; Leister K; Joshi L; Rudd PM
Methods; 2017 Mar; 116():63-83. PubMed ID: 27832969
[TBL] [Abstract][Full Text] [Related]
16. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
Gawlitzek M; Ryll T; Lofgren J; Sliwkowski MB
Biotechnol Bioeng; 2000 Jun; 68(6):637-46. PubMed ID: 10799988
[TBL] [Abstract][Full Text] [Related]
17. Correlative N-glycan and charge variant analysis of cetuximab expressed in murine, chinese hamster and human expression systems.
Trappe A; Füssl F; Millán-Martín S; Ronan R; Zaborowska I; Bones J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123186. PubMed ID: 35240429
[TBL] [Abstract][Full Text] [Related]
18. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells.
Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ
Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Culture Temperature on the Aggregation of Recombinant TNFR-Fc is Regulated by the PERK-eIF2a Pathway in CHO Cells.
Wang K; Zhang T; Chen J; Liu C; Tang J; Xie Q
Protein Pept Lett; 2018; 25(6):570-579. PubMed ID: 29848262
[TBL] [Abstract][Full Text] [Related]
20. Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies.
Villacrés C; Tayi VS; Butler M
J Biotechnol; 2021 Jun; 333():49-62. PubMed ID: 33901620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
